
ESTRO/X
Jun 12, 2025, 07:25
Preliminary Results from the POTEN-C Trial – ESTRO
European SocieTy for Radiotherapy and Oncology (ESTRO) shared a post on X:
“Can radiotherapy preserve sexual function in prostate cancer patients? Early results from the POTEN-C trial, presented at ESTRO25, suggest yes. Neurovascular-sparing SAbR led to less toxicity and better early QoL outcomes.”
More posts featuring ESTRO.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Aug 24, 2025, 04:55
Aug 24, 2025, 01:32
Aug 23, 2025, 22:57
Aug 23, 2025, 22:35
Aug 23, 2025, 22:10
Aug 23, 2025, 21:42
Aug 23, 2025, 21:31